Dr. Robert Bernard Devney , MD
Psychiatry & Neurology - Psychiatry • Bothell, WA
19515 North Creek Pkwy, Ste 202
Bothell, WA 980118200
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Robert Devney is listed in NPPES under Psychiatry & Neurology - Psychiatry.
-
NPI assigned on October 27, 2006; this date does not establish years in practice.
-
Published CMS data list 644 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Lamotrigine — 55 prescription fills, including refills.
- Quetiapine Fumarate — 51 prescription fills, including refills.
- Aripiprazole — 49 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 28 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 65% of clinicians listed under Psychiatry & Neurology - Psychiatry in Washington (2024, 469 clinicians with data). Median for this group: 268. Middle half: 64 to 800.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 463 in 2020 to 644 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
19515 North Creek Pkwy
Ste 202
Bothell, WA 980118200
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Psychiatry & Neurology - Psychiatry: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
718 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$31,557 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $946.32 across 48 records.
By nature of payment
- Food and Beverage: $946.32 across 48 records.
Reporting-company totals (3 largest of 17)
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.): $166.31 across 16 records.
- ABBVIE INC.: $100.25 across 4 records.
- Janssen Pharmaceuticals, Inc: $80.75 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Can order Medicare-covered services
CMS lists Dr. Devney as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Bothell and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Psychiatry & Neurology - Psychiatry in Washington (2024, 469 clinicians with data). Median for this group: 268. Middle half: 64 to 800.
Too few clinicians listed under Psychiatry & Neurology - Psychiatry in Bothell have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 65% of clinicians listed under Psychiatry & Neurology - Psychiatry in Washington (2024, 469 clinicians with data). Median for this group: $7,696. Middle half: $1,167 to $48,578.
Too few clinicians listed under Psychiatry & Neurology - Psychiatry in Bothell have Medicare Part D data for 2024 to compare.
11 active clinicians are listed under Psychiatry & Neurology - Psychiatry with a practice address in Bothell, WA (1,195 in Washington).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Bothell
45.5% of these 11 clinicians have the CMS telehealth indicator.
45.5% of these 11 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 39% from 463 in 2020 to 644 in 2024.
- 2020: 463
- 2021: 522
- 2022: 570
- 2023: 717
- 2024: 644
-
30-day fills
30-day fills increased 41% from 507 in 2020 to 718 in 2024.
- 2020: 507
- 2021: 559
- 2022: 614
- 2023: 792
- 2024: 718
-
Part D drug cost
Part D drug cost decreased 27% from $42,970 in 2020 to $31,557 in 2024.
- 2020: $42,970
- 2021: $70,179
- 2022: $68,181
- 2023: $73,374
- 2024: $31,557
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $111.02 in 2021 to $946.32 in 2025.
- 2021: $111.02
- 2022: $347.63
- 2023: $707.97
- 2024: $756.57
- 2025: $946.32
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 48 records totaling $946.32.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $32.31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $31.93 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $30.72 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $29.89 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
INVEGA SUSTENNA | General | $29.49 |
| Alkermes, Inc. |
Food and Beverage
In-kind items and services
|
LYBALVI | General | $28.91 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
AUSTEDO XR | General | $28.04 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $27.91 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SPRAVATO | General | $27.84 |
| Alkermes, Inc. |
Food and Beverage
In-kind items and services
|
LYBALVI | General | $26.81 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
UZEDY | General | $26.35 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $26.15 |
| Sage Therapeutics, LLC |
Food and Beverage
In-kind items and services
|
ZURZUVAE | General | $26.10 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $26.04 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $25.65 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $25.57 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $25.17 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $24.90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $24.54 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $24.54 |
| Tris Pharma Inc |
Food and Beverage
In-kind items and services
|
Dyanavel XR | General | $24.40 |
| Tris Pharma Inc |
Food and Beverage
In-kind items and services
|
Dyanavel XR | General | $24.11 |
| Sage Therapeutics, LLC |
Food and Beverage
In-kind items and services
|
ZURZUVAE | General | $23.99 |
| Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
APLENZIN | General | $23.97 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SPRAVATO | General | $23.42 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Lamotrigine | Lamotrigine | 55 | 1,894 | $797.56 | — |
| Quetiapine Fumarate | Quetiapine Fumarate | 51 | 1,135 | $764.60 | — |
| Aripiprazole | Aripiprazole | 49 | 1,464 | $1,257.93 | — |
| Sertraline Hcl | Sertraline Hcl | 47 | 1,686 | $390.04 | — |
| Clonazepam | Clonazepam | 38 | 1,088 | $427.90 | — |
| Oxcarbazepine | Oxcarbazepine | 38 | 1,068 | $2,657.46 | — |
| Citalopram Hbr | Citalopram Hydrobromide | 36 | 1,032 | $109.20 | — |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | 1,286 | $337.88 | — |
| Clomipramine Hcl | Clomipramine Hcl | 26 | 732 | $1,242.97 | — |
| Adderall Xr | Dextroamphetamine/Amphetamine | 24 | 720 | $5,830.36 | — |
| Atomoxetine Hcl | Atomoxetine Hcl | 22 | 659 | $1,816.16 | — |
| Clonidine Hcl | Clonidine Hcl | 19 | 407 | $109.50 | — |
| Ziprasidone Hcl | Ziprasidone Hcl | 17 | 810 | $836.60 | — |
| Propranolol Hcl | Propranolol Hcl | 16 | 464 | $263.77 | — |
| Memantine Hcl | Memantine Hcl | 16 | 634 | $1,118.48 | — |
| Metformin Hcl Er | Metformin Hcl | 15 | 450 | $61.85 | — |
| Benztropine Mesylate | Benztropine Mesylate | 14 | 403 | $199.02 | — |
| Risperidone | Risperidone | 13 | 376 | $224.30 | — |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 13 | 364 | $562.23 | — |
| Levocarnitine | Levocarnitine | 13 | 368 | $2,795.62 | — |
| Guanfacine Hcl Er | Guanfacine Hcl | 13 | 366 | $584.25 | — |
| Alprazolam | Alprazolam | 12 | 600 | $93.76 | — |
| Clozapine | Clozapine | 12 | 360 | $943.50 | — |
| Concerta | Methylphenidate Hcl | 12 | 360 | $4,825.10 | — |
| Paliperidone Er | Paliperidone | 12 | 359 | $2,799.19 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 2084P0800X
A Psychiatrist specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
NUCC Taxonomy Code: 2084P0804X
Child & Adolescent Psychiatry is a subspecialty of psychiatry with additional skills and training in the diagnosis and treatment of developmental, behavioral, emotional, and mental disorders of childhood and adolescence.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 19515 NORTH CREEK PKWY, STE 202, BOTHELL, WA 980118200 (Tel: 4259490204)
Registered at 19515 NORTH CREEK PKWY, STE 202, BOTHELL, WA 980118200 (Tel: 4259490204)
Recorded as ROBERT DEVNEY, MD
Psychiatry & Neurology (license number reported to NPPES: WA MD00019763)
NPI status registered as active in NPPES database
Registered at 18500 156TH AVE N.E., SUITE #100, WOODINVILLE, WA 980724470 (Tel: 4254810429)
Registered at 18500 156TH AVE N.E., SUITE #100, WOODINVILLE, WA 980724470 (Tel: 4254810429)
Recorded as ROBERT DEVNEY, M.D.
Psychiatry & Neurology (license number reported to NPPES: WA MD00019763)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Psychiatry & Neurology - Psychiatry Specialists in Bothell
Healthcare providers in BothellMailing Address
19515 North Creek Pkwy, Ste 202
Bothell, WA 980118200
Phone: 4259490204